Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shih-Jen Liu

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 2, 2013
A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunityYing-Chyi Song, Han-Yin Cheng, Chih-Hsiang Leng, et al.
Journal of Virology|August 1, 2014
Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patternsHung-Bo Hsiao, Ai-Hsiang Chou, Su-I Lin, et al.
Scientific Reports|April 12, 2016
Carboxyl-terminal fusion of E7 into Flagellin shifts TLR5 activation to NLRC4/NAIP5 activation and induces TLR5-independent anti-tumor immunityKuo-Hsing Lin, Li-Sheng Chang, Chun-Yuan Tian, et al.
Biosensors|August 25, 2022
Measurements of Anti-SARS-CoV-2 Antibody Levels after Vaccination Using a SH-SAW BiosensorChia-Hsuan Cheng, Yu-Chi Peng, Shu-Min Lin, et al.
Frontiers in Oncology|November 1, 2012
Recombinant heat shock protein 70 in combination with radiotherapy as a source of tumor antigens to improve dendritic cell immunotherapyYu-Shan Wang, Shih-Jen Liu, Su-Chen Huang, et al.
Journal for Immunotherapy of Cancer|October 10, 2020
Nanoemulsion adjuvantation strategy of tumor-associated antigen therapy rephrases mucosal and immunotherapeutic signatures following intranasal vaccinationChung-Hsiung Huang, Chiung-Yi Huang, Hui-Min Ho, et al.
Vaccine: X|August 7, 2019
Immunological evaluation of a novel HLA-A2 restricted phosphopeptide of tumor associated Antigen, TRAP1, on cancer therapyMin-Han Lin, Kuan-Yin Shen, Bing-Sin Liu, et al.
Journal of Medical Virology|August 28, 2023
Co-delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1-dominant humoral and cellular immunity against SARS-CoV-2Hung-Chun Liao, Min-Syuan Huang, Fang-Feng Chiu, et al.
Vaccines|October 24, 2020
A Polypeptide of Tumor-Associated Antigen L6 with Intrinsic Adjuvant Activity Enhances Antitumor ImmunityYuh-Pyng Sher, Kit Man Chai, Wen-Ching Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 11, 2016
A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunityKuan-Yin Shen, Hsin-Yu Liu, Hui-Ju Li, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 2, 2013
A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunityYing-Chyi Song, Han-Yin Cheng, Chih-Hsiang Leng, et al.
Journal of Virology|August 1, 2014
Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patternsHung-Bo Hsiao, Ai-Hsiang Chou, Su-I Lin, et al.
Scientific Reports|April 12, 2016
Carboxyl-terminal fusion of E7 into Flagellin shifts TLR5 activation to NLRC4/NAIP5 activation and induces TLR5-independent anti-tumor immunityKuo-Hsing Lin, Li-Sheng Chang, Chun-Yuan Tian, et al.
Biosensors|August 25, 2022
Measurements of Anti-SARS-CoV-2 Antibody Levels after Vaccination Using a SH-SAW BiosensorChia-Hsuan Cheng, Yu-Chi Peng, Shu-Min Lin, et al.
Frontiers in Oncology|November 1, 2012
Recombinant heat shock protein 70 in combination with radiotherapy as a source of tumor antigens to improve dendritic cell immunotherapyYu-Shan Wang, Shih-Jen Liu, Su-Chen Huang, et al.
Journal for Immunotherapy of Cancer|October 10, 2020
Nanoemulsion adjuvantation strategy of tumor-associated antigen therapy rephrases mucosal and immunotherapeutic signatures following intranasal vaccinationChung-Hsiung Huang, Chiung-Yi Huang, Hui-Min Ho, et al.
Vaccine: X|August 7, 2019
Immunological evaluation of a novel HLA-A2 restricted phosphopeptide of tumor associated Antigen, TRAP1, on cancer therapyMin-Han Lin, Kuan-Yin Shen, Bing-Sin Liu, et al.
Journal of Medical Virology|August 28, 2023
Co-delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1-dominant humoral and cellular immunity against SARS-CoV-2Hung-Chun Liao, Min-Syuan Huang, Fang-Feng Chiu, et al.
Vaccines|October 24, 2020
A Polypeptide of Tumor-Associated Antigen L6 with Intrinsic Adjuvant Activity Enhances Antitumor ImmunityYuh-Pyng Sher, Kit Man Chai, Wen-Ching Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 11, 2016
A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunityKuan-Yin Shen, Hsin-Yu Liu, Hui-Ju Li, et al.
Pageof 12